These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 30866828)
1. Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan. Lin WP; Huang YS; Wang JT; Chen YC; Chang SC BMC Infect Dis; 2019 Mar; 19(1):245. PubMed ID: 30866828 [TBL] [Abstract][Full Text] [Related]
3. Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital. Lee S; Han SW; Kim KW; Song DY; Kwon KT Korean J Intern Med; 2014 Jan; 29(1):49-56. PubMed ID: 24574833 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial Resistance as Risk Factor for Recurrent Bacteremia after Staphylococcus aureus, Escherichia coli, or Klebsiella spp. Community-Onset Bacteremia. Abbara S; Guillemot D; Smith DRM; El Oualydy S; Kos M; Poret C; Breant S; Brun-Buisson C; Watier L Emerg Infect Dis; 2024 May; 30(5):974-983. PubMed ID: 38666612 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors. Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633 [TBL] [Abstract][Full Text] [Related]
6. Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study. Aiken AM; Rehman AM; de Kraker MEA; Madrid L; Kebede M; Labi AK; Obeng-Nkrumah N; Nyamwaya B; Kagucia E; Cocker D; Kawaza K; Lester R; Iregbu KC; Medugu N; Nwajiobi-Princewill PI; Dramowski A; Sonda T; Hemed A; Fwoloshi S; Ojok D; Scott JAG; Whitelaw A; Lancet Infect Dis; 2023 Nov; 23(11):1280-1290. PubMed ID: 37454672 [TBL] [Abstract][Full Text] [Related]
7. E. coli, K. pneumoniae and K. oxytoca community-acquired infections susceptibility to cephalosporins and other antimicrobials in Lebanon. Moghnieh RA; Musharrafieh UM; Husni RN; Abboud E; Haidar M; Abboud E; Abou Shakra D J Med Liban; 2014; 62(2):107-12. PubMed ID: 25011373 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721 [TBL] [Abstract][Full Text] [Related]
9. Impact of the administration of a third-generation cephalosporin (3GC) to one-day-old chicks on the persistence of 3GC-resistant Escherichia coli in intestinal flora: An in vivo experiment. Baron S; Jouy E; Touzain F; Bougeard S; Larvor E; de Boisseson C; Amelot M; Keita A; Kempf I Vet Microbiol; 2016 Mar; 185():29-33. PubMed ID: 26931388 [TBL] [Abstract][Full Text] [Related]
10. Association between the rate of third generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae and antibiotic consumption based on 143 Chinese tertiary hospitals data in 2014. Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1495-1502. PubMed ID: 32221726 [TBL] [Abstract][Full Text] [Related]
11. Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27. Harris PNA; Ben Zakour NL; Roberts LW; Wailan AM; Zowawi HM; Tambyah PA; Lye DC; Jureen R; Lee TH; Yin M; Izharuddin E; Looke D; Runnegar N; Rogers B; Bhally H; Crowe A; Schembri MA; Beatson SA; Paterson DL; J Antimicrob Chemother; 2018 Mar; 73(3):634-642. PubMed ID: 29253152 [TBL] [Abstract][Full Text] [Related]
12. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Rodríguez-Baño J; Picón E; Gijón P; Hernández JR; Ruíz M; Peña C; Almela M; Almirante B; Grill F; Colomina J; Giménez M; Oliver A; Horcajada JP; Navarro G; Coloma A; Pascual A; Clin Infect Dis; 2010 Jan; 50(1):40-8. PubMed ID: 19995215 [TBL] [Abstract][Full Text] [Related]
13. Factors that impact on the burden of Escherichia coli bacteraemia: multivariable regression analysis of 2011-2015 data from West London. Blandy O; Honeyford K; Gharbi M; Thomas A; Ramzan F; Ellington MJ; Hope R; Holmes AH; Johnson AP; Aylin P; Woodford N; Sriskandan S J Hosp Infect; 2019 Feb; 101(2):120-128. PubMed ID: 30403958 [TBL] [Abstract][Full Text] [Related]
14. WGS-based surveillance of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark. Roer L; Hansen F; Thomsen MCF; Knudsen JD; Hansen DS; Wang M; Samulioniené J; Justesen US; Røder BL; Schumacher H; Østergaard C; Andersen LP; Dzajic E; Søndergaard TS; Stegger M; Hammerum AM; Hasman H J Antimicrob Chemother; 2017 Jul; 72(7):1922-1929. PubMed ID: 28369408 [TBL] [Abstract][Full Text] [Related]
15. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes. Park SH; Choi SM; Lee DG; Kim J; Choi JH; Kim SH; Kwon JC; Yoo JH Microb Drug Resist; 2011 Dec; 17(4):537-44. PubMed ID: 21875342 [TBL] [Abstract][Full Text] [Related]
16. Risk factors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli bacteremia. Park YS; Bae IK; Kim J; Jeong SH; Hwang SS; Seo YH; Cho YK; Lee K; Kim JM Yonsei Med J; 2014 Mar; 55(2):467-75. PubMed ID: 24532519 [TBL] [Abstract][Full Text] [Related]
17. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. de Kraker ME; Wolkewitz M; Davey PG; Koller W; Berger J; Nagler J; Icket C; Kalenic S; Horvatic J; Seifert H; Kaasch A; Paniara O; Argyropoulou A; Bompola M; Smyth E; Skally M; Raglio A; Dumpis U; Melbarde Kelmere A; Borg M; Xuereb D; Ghita MC; Noble M; Kolman J; Grabljevec S; Turner D; Lansbury L; Grundmann H J Antimicrob Chemother; 2011 Feb; 66(2):398-407. PubMed ID: 21106563 [TBL] [Abstract][Full Text] [Related]
18. Genomic epidemiology of third-generation cephalosporin-resistant Mounsey O; Marchetti L; Parada J; Alarcón LV; Aliverti F; Avison MB; Ayala CS; Ballesteros C; Best CM; Bettridge J; Buchamer A; Buldain D; Carranza A; Corti Isgro M; Demeritt D; Escobar MP; Gortari Castillo L; Jaureguiberry M; Lucas MF; Madoz LV; Marconi MJ; Moiso N; Nievas HD; Ramirez Montes De Oca MA; Reding C; Reyher KK; Vass L; Williams S; Giraudo J; De La Sota RL; Mestorino N; Moredo FA; Pellegrino M Appl Environ Microbiol; 2024 Mar; 90(3):e0179123. PubMed ID: 38334306 [TBL] [Abstract][Full Text] [Related]
19. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis. Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741 [TBL] [Abstract][Full Text] [Related]